China Swine Industry ›› 2021, Vol. 16 ›› Issue (2): 63-68.
• Swine Disease Prevention and Control • Previous Articles Next Articles
ZHANG Xinyi1, WANG Xiaowu1, WANG Guibo2, LUO Chaoying1,2,*, ZHENG Jifang1,2
CLC Number:
[1] 绿养追踪者. “减抗/替抗”之路,焉能“只说不练”[EB/OL]. http://www.feedtrade.com.cn/technology/lvyang/jianzheng/2017-11-07/2017473.html. [2] 中国农网. 福建、河南、江苏、吉林等省出台政策推进饲料“禁抗”、养殖“减抗”[EB/OL]. http://www.fishfirst.cn/article-114983-1.html. [3] 牧科学院. 农业农村部发布2019 年中国兽用抗菌药使用情况报告[EB/OL]. https://mp.weixin.qq.com/s/P0McVz8xvAuUK9HfXQldzQ. [4] 中国食品安全网. 猪肉频频被通报抗生素超标!为防治疾病,过量用药或为主因[EB/OL].https://www.163.com/dy/article/EJH2Q8IH0514CIOC.html. [5] 李嘉鑫. 广州一超市猪肉检出抗生素!企业回应[EB/OL]. https://www.360kuai.com/pc/9550302d75c68baf3?cota=3&kuai_so=1&sign=360_57c3bbd1&refer_scene=so_1. [6] 罗超应, 王贵波, 李锦宇, 等. 欧盟减抗教训与减抗科学观念转变[J]. 中兽医医药杂志, 2019, 38(6):99-102. [7] Mavromichalis I.12 feed antibiotic reduction lessons from EU producers[J]. Feed Strategy, 2019, 70(1):36-38. [8] 李明魁. 中兽药产业的发展历史及特色优势[J]. 中国动物保健, 2009, 11(6):28-32. [9] 中国产业信息网. 2019年中国兽药行业发展现状分析[EB/OL]. http://www.chyxx.com/industry/202006/872104.html. [10] 佟建明. 饲用抗生素的促生长作用机制及其替代技术研究[J]. 饲料工业, 2006, 27(2):1-4. [11] Liu XY, Liu F, Ding SY, et al.Sublethal levels of antibiotics promote bacterial persistence in epithelial cells[J]. Advanced Science, 2020, 7(18):1-13. [12] 张显东. 促生长抗生素作用机理及其替代方案的重新思考[J]. 饲料工业, 2017, 38(11):61-64. [13] 沈建忠. 养殖业发展仍离不开抗菌药物,合理、谨慎使用是关键[J]. 北方牧业, 2017(16):11. [14] 陈墨. 屠呦呦:不在意是不是“三无教授”是否得奖无所谓[EB/OL]. http://scitech.people.com.cn/n/2015/1007/c1007-27668713.html. [15] 罗超应, 李锦宇, 王贵波, 等. 走出中兽药防治畜禽疾病的误区[J]. 中国兽医杂志, 2017, 53(2):58-61. [16] 乔富渠. 怎样拓宽温病治法领域[J]. 陕西中医学院学报, 1991, 14(2):1-4. [17] 陈士奎. 我国开创的中西医结合科研及其启示(七)——著名危重病急救医学家王今达教授与中西医结合急救学研究[J]. 中国中西医结合杂志, 2017, 37(4):394-397. [18] 罗超应, 罗磐真, 王贵波, 等. 中西医药学结合的困惑与复杂性科学分析[J]. 自然辩证法通讯, 2020, 42(3):101-105. [19] 仲学峰. 沈建忠院士关于抗菌药物的兽医应用趋势报告[EB/OL]. https://www.sohu.com/a/240205039_715506. [20] 罗超应, 李锦宇, 王贵波, 等. 抗生素的根本出路在合理应用[J]. 中国合理用药探索, 2018, 15(3):72-75. [21] 罗超应, 李锦宇, 王贵波, 等. 抗生素安全使用的复杂性科学探讨[J]. 国外医药抗生素分册, 2014, 35(6):246-249. [22] 罗悦性. 抗生素治疗感染性疾病失败原因的探讨[J]. 中国医药导报, 2006, 3(18):70-72. [23] 罗超应, 罗磐真, 李锦宇, 等. 医学模式转变之困惑及其复杂性探讨[J]. 中国社会医学杂志, 2017, 34(1):1-3. [24] 罗超应, 罗磐真, 王贵波, 等. 基于复杂性科学论中医药学特色与优势[J]. 中国中医基础医学杂志, 2018, 24(10):1368-1372. [25] 罗超应, 罗磐真, 王贵波, 等. 整合医学范式建立与科学观念转变[J]. 医学争鸣, 2020, 11(6):1-5. [26] Global MD. “人民的希望”瑞德西韦让业界专家大失所望![EB/OL]. http://finance.sina.com.cn/stock/relnews/us/2020-03-17/doc-iimxxstf9769290.shtml. [27] Wang ML, Cao RY, Zhang LK, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro[J]. Cell Research, 2020(30):269-271. [28] Li RF, Hou YL, Huang JC, et al.Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)[J]. Pharmacological Research, 2020, doi: https://doi.org/10.1016/j.phrs.2020.104761. [29] 曾莉. 湖北61449名新冠肺炎患者使用中医药治疗总有效率达90%以上[EB/OL]. https://www.chinanews.com/sh/2020/03-24/9135538.shtml. [30] Pan H, Peto R, Henao-Restrepo AM, et al.Repurposed antiviral drugs for COVID-19-interim WHO solidarity trial results[J]. New England Journal of Medicine,2020, doi:10.1056/NEJMoa2023184. [31] Marovich M, Mascola JR, Cohen MS.Monoclonal antibodies for prevention and treatment of COVID-19[J]. JAMA The Journal of the American Medical Association, 2020, doi:10.1001/jama.2020.10245. [32] Downing NS, Shah ND, Aminawung JA, et al.Postmarket safety events among novel therapeutics approved by the US Food and Drug Administration between 2001 and 2010[J]. JAMA The Journal of the American Medical Association, 2017, 317(18):1854-1863. [33] 罗超应, 罗磐真, 王贵波, 等. 临床医学认识方法的完善与中西医学辨证与辨病相结合[J]. 医学争鸣, 2020, 11(1):61-65. [34] 蒋健. 某些科学家宁可无药也反对用中医药,是何逻辑?[EB/OL]. https://baijiahao.baidu.com/s?id=1667889729030622724. [35] Weeks J.Call to Action: Announcing the Traditional, Complementary and Integrative Health and Medicine COVID-19 Support Registry[J].The Journal of the Alternative and Complementary Medicine, 2020, 26(4):256-258. |
[1] | . [J]. China Swine Industry, 2021, 16(1): 24-27. |
[2] | . [J]. China Swine Industry, 2021, 16(1): 28-33. |
[3] | . [J]. China Swine Industry, 2021, 16(1): 34-37. |
[4] | . [J]. China Swine Industry, 2021, 16(1): 38-42. |
[5] | . [J]. China Swine Industry, 2021, 16(1): 43-45. |
[6] | YAN Ying, CHEN Xiaoling, LIU Yan, XU Xuewen, MA Guojian. Comparison on the Litter Size of Three-way and Two-way Crossbred Sows in an Enterprise in the Circumstance of African Swine Fever [J]. China Swine Industry, 2021, 16(1): 46-51. |
[7] | . [J]. China Swine Industry, 2021, 16(1): 52-54. |
[8] | . [J]. China Swine Industry, 2021, 16(1): 55-58. |
[9] | WEI Baohua, WANG Yangjie, HAN Shuguang. Effects of Feed with Different Proportions of Corn Citric Acid Residue on Weight Gain of Fattening Pigs [J]. China Swine Industry, 2021, 16(1): 59-63. |
[10] | . [J]. China Swine Industry, 2021, 16(1): 64-67. |
[11] | . [J]. China Swine Industry, 2021, 16(1): 68-69. |
[12] | Sun Shengfu, Zhang Yue, Xue Ruixue, Xing Linlin, Chen Shumin, Tian Fulin. Analysis of Immunization Monitoring of Major Animal Diseases in Some Breeding Pig Farms in Shandong Province [J]. China Swine Industry, 2021, 16(1): 70-73. |
[13] | . [J]. China Swine Industry, 2021, 16(1): 74-76. |
[14] | . [J]. China Swine Industry, 2021, 16(1): 77-79. |
[15] | . [J]. China Swine Industry, 2021, 16(1): 80-82. |
|